ADPT logo

Adaptive Biotechnologies (ADPT) Cash from operations

annual CFO:

-$95.21M+$61.11M(+39.09%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADPT annual cash flow from operations is -$95.21 million, with the most recent change of +$61.11 million (+39.09%) on December 31, 2024.
  • During the last 3 years, ADPT annual CFO has risen by +$97.52 million (+50.60%).
  • ADPT annual CFO is now -146.35% below its all-time high of $205.40 million, reached on December 31, 2019.

Performance

1-year change

+39.09%

3-year change

+50.6%

5-year change

-146.35%

15-year change

-173.14%

ADPT Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

14.98%
ADPT annual cash flow from operations is higher than 14.98% of companies in Healthcare sector

Range

All-time high

$205.40M
ADPT annual cash flow from operations is currently -146.35% below its historical high of $205.40 million

3-year low

-$192.73M

Earnings dates

Last annual earnings report date

Dec 31, 2024
ADPT previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
ADPT next annual earnings announcement has not yet been scheduled

OtherADPTcash flow metrics

annual CFI

$77.79M
ADPT annual cash flow from investing activities is $77.79 million

annual CFF

$241.00K
ADPT annual cash flow from financing activities is $241.00 thousand

annual FCF

-$98.88M
ADPT annual free cash flow is -$98.88 million

annual CAPEX

$3.66M
ADPT annual capital expenditures is $3.66 million

quarterly CFO:

-$28.48M-$15.99M(-128.04%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT quarterly cash flow from operations is -$28.48 million, with the most recent change of -$15.99 million (-128.04%) on March 31, 2025.
  • Over the past year, ADPT quarterly CFO has increased by +$9.87 million (+25.73%).
  • ADPT quarterly CFO is now -110.23% below its all-time high of $278.30 million, reached on March 31, 2019.

Performance

3-month change

-128.04%

1-year change

+25.73%

3-year change

+55.81%

5-year change

+9.88%

ADPT quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

16.55%
ADPT quarterly cash flow from operations is higher than 16.55% of companies in Healthcare sector

Range

All-time high

$278.30M
ADPT quarterly cash flow from operations is currently -110.23% below its historical high of $278.30 million

3-year low

-$64.45M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
ADPT previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 1, 2025
ADPT next earnings announcement is scheduled for Aug 1, 2025

OtherADPTcash flow metrics

quarterly CFI

$25.57M
ADPT quarterly cash flow from investing activities is $25.57 million

quarterly CFF

$5.45M
ADPT quarterly cash flow from financing activities is $5.45 million

quarterly FCF

-$29.74M
ADPT quarterly free cash flow is -$29.74 million

quarterly CAPEX

$1.26M
ADPT quarterly capital expenditures is $1.26 million

TTM CFO:

-$85.34M+$9.87M(+10.37%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADPT TTM cash flow from operations is -$85.34 million, with the most recent change of +$9.87 million (+10.37%) on March 31, 2025.
  • Over the past year, ADPT TTM CFO has increased by +$50.18 million (+37.03%).
  • ADPT TTM CFO is now -133.85% below its all-time high of $252.14 million, reached on March 31, 2019.

Performance

3-month change

+10.37%

1-year change

+37.03%

3-year change

+57.1%

5-year change

+18.34%

ADPT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

17.33%
ADPT TTM cash flow from operations is higher than 17.33% of companies in Healthcare sector

Range

All-time high

$252.14M
ADPT TTM cash flow from operations is currently -133.85% below its historical high of $252.14 million

3-year low

-$208.79M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
ADPT previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 1, 2025
ADPT next earnings announcement is scheduled for Aug 1, 2025

OtherADPTcash flow metrics

TTM CFI

$58.86M
ADPT TTM cash flow from investing activities is $58.86 million

TTM CFF

$5.65M
ADPT TTM cash flow from financing activities is $5.65 million

TTM FCF

-$88.75M
ADPT TTM free cash flow is -$88.75 million

TTM CAPEX

$3.41M
ADPT TTM capital expenditures is $3.41 million

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ADPT Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+39.1%+25.7%+37.0%
3 y3 years+50.6%+55.8%+57.1%
5 y5 years-146.3%+9.9%+18.3%

ADPT Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+50.6%-128.0%+55.8%at high+59.1%
5 y5-year-146.3%+50.6%-128.0%+55.8%at high+59.1%
alltimeall time-146.3%+50.6%-110.2%+55.8%-133.8%+59.1%

ADPT Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$28.48M(+128.0%)
-$85.34M(-10.4%)
Dec 2024
-$95.21M(-39.1%)
-$12.49M(-53.8%)
-$95.21M(-13.2%)
Sep 2024
-
-$27.07M(+56.4%)
-$109.65M(-15.2%)
Jun 2024
-
-$17.30M(-54.9%)
-$129.27M(-4.6%)
Mar 2024
-
-$38.35M(+42.4%)
-$135.53M(-13.3%)
Dec 2023
-$156.32M(-15.0%)
-$26.93M(-42.3%)
-$156.32M(-1.9%)
Sep 2023
-
-$46.68M(+98.2%)
-$159.41M(+2.8%)
Jun 2023
-
-$23.56M(-60.2%)
-$155.13M(-13.2%)
Mar 2023
-
-$59.15M(+97.0%)
-$178.64M(-2.9%)
Dec 2022
-$183.94M(-4.6%)
-$30.02M(-29.2%)
-$183.94M(-11.5%)
Sep 2022
-
-$42.41M(-9.9%)
-$207.75M(-0.5%)
Jun 2022
-
-$47.06M(-27.0%)
-$208.79M(+5.0%)
Mar 2022
-
-$64.45M(+19.7%)
-$198.94M(+3.2%)
Dec 2021
-$192.73M
-$53.83M(+23.9%)
-$192.73M(+7.8%)
Sep 2021
-
-$43.44M(+16.7%)
-$178.75M(-2.0%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$37.21M(-36.1%)
-$182.46M(+3.5%)
Mar 2021
-
-$58.24M(+46.2%)
-$176.32M(+17.8%)
Dec 2020
-$149.68M(-172.9%)
-$39.84M(-15.5%)
-$149.68M(+9.6%)
Sep 2020
-
-$47.16M(+51.7%)
-$136.63M(+14.2%)
Jun 2020
-
-$31.08M(-1.7%)
-$119.61M(+14.5%)
Mar 2020
-
-$31.61M(+18.0%)
-$104.50M(-150.9%)
Dec 2019
$205.40M(-736.7%)
-$26.79M(-11.1%)
$205.40M(-9.4%)
Sep 2019
-
-$30.14M(+88.7%)
$226.78M(-7.5%)
Jun 2019
-
-$15.97M(-105.7%)
$245.24M(-2.7%)
Mar 2019
-
$278.30M(-5244.2%)
$252.14M(-881.6%)
Dec 2018
-$32.26M(-7.5%)
-$5.41M(-53.7%)
-$32.26M(+20.1%)
Sep 2018
-
-$11.69M(+28.9%)
-$26.85M(+77.1%)
Jun 2018
-
-$9.07M(+48.7%)
-$15.16M(+148.7%)
Mar 2018
-
-$6.10M
-$6.10M
Dec 2017
-$34.86M
-
-

FAQ

  • What is Adaptive Biotechnologies annual cash flow from operations?
  • What is the all time high annual CFO for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies annual CFO year-on-year change?
  • What is Adaptive Biotechnologies quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies quarterly CFO year-on-year change?
  • What is Adaptive Biotechnologies TTM cash flow from operations?
  • What is the all time high TTM CFO for Adaptive Biotechnologies?
  • What is Adaptive Biotechnologies TTM CFO year-on-year change?

What is Adaptive Biotechnologies annual cash flow from operations?

The current annual CFO of ADPT is -$95.21M

What is the all time high annual CFO for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high annual cash flow from operations is $205.40M

What is Adaptive Biotechnologies annual CFO year-on-year change?

Over the past year, ADPT annual cash flow from operations has changed by +$61.11M (+39.09%)

What is Adaptive Biotechnologies quarterly cash flow from operations?

The current quarterly CFO of ADPT is -$28.48M

What is the all time high quarterly CFO for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high quarterly cash flow from operations is $278.30M

What is Adaptive Biotechnologies quarterly CFO year-on-year change?

Over the past year, ADPT quarterly cash flow from operations has changed by +$9.87M (+25.73%)

What is Adaptive Biotechnologies TTM cash flow from operations?

The current TTM CFO of ADPT is -$85.34M

What is the all time high TTM CFO for Adaptive Biotechnologies?

Adaptive Biotechnologies all-time high TTM cash flow from operations is $252.14M

What is Adaptive Biotechnologies TTM CFO year-on-year change?

Over the past year, ADPT TTM cash flow from operations has changed by +$50.18M (+37.03%)
On this page